EverHint – EMA10 × EMA30 Crossover Signals for Jan 26, 2026 – Consumer Cyclical Leads with 12 Setups
41 signals. Consumer Cyclical leads (12). 7 with insider selling. 3 with insider buying. 2 with congressional buying. price range $3-$622. RSI 31-77. sectors: Consumer Cyclical (12), Financial Services (8), Real Estate (6). 2 report earnings within 7 days. full analyst coverage, 51.2% have news.
EverHint – EMA10 × EMA30 Crossover Signals for Jan 12, 2026 – Healthcare Leads with 13 Setups
Excerpt: 68 signals. Healthcare leads (13). 17 with insider selling. 1 with insider buying. price range $2-$605. RSI 15-94. sectors: Healthcare (13), Technology (13), Consumer Cyclical (10). 1 report earnings within 7 days. 32.4% have news.
EverHint – EMA10 x EMA30 Crossover Signals for Jan 09, 2026 – Healthcare Leads with 20 Setups
79 signals. Healthcare leads (20). 22 with insider selling. 8 with insider buying. price range $2-$925. RSI 15-88. sectors: Healthcare (20), Consumer Cyclical (12), Technology (10). full analyst coverage, 27.8% have news.
EverHint Signal — EMA10 × EMA30 Crossover — January 8, 2026
68 buy signals emerge as EMA10 crosses above EMA30, led by Healthcare and Industrials. Markets show cautious optimism with S&P +0.07%, VIX at 15.45 signals calm conditions—ideal for swing trades targeting 1-4 week holds.
EverHint Signal — EMA10 × EMA30 Crossover — January 07, 2026
EMA10×EMA30 signals trigger on 84 stocks as markets slip 0.35%. Buy-side dominated by industrials and healthcare; sell-side heavy in energy and real estate. VIX elevated at 15.38 signals cautious environment.
EverHint Signal — EMA10 × EMA30 Crossover (Top 15 ranked by RSI) — January 06, 2026
EMA10 × EMA30 crossover signals light up January 6 with 66 buy setups and 29 sell warnings. Tech momentum builds as NICE surges with 89 RSI, while healthcare names like AVTR and OGN flash deep value entries. Markets drift higher with S&P at new highs, but elevated VIX signals caution ahead.
EverHint Signal — EMA10 × EMA30 Crossover — January 05, 2026
EMA10 crossed above EMA30 for 48 stocks and below for 36 on January 5th. Top momentum shifts include TIGR, UUUU, BN, and MEDP on the buy side, while GEN, KDP, RYTM, and NSC triggered sell signals. Markets mixed with elevated VIX at 14.9.
EverHint Signal — EMA10 × EMA30 Crossover — January 02, 2026
Fresh EMA10×EMA30 crossovers hit 61 stocks on Jan 2nd: 37 buy signals (energy names surge, CVX/EQNR/SHEL lead), 24 sell signals (tech/financial stress). Markets mixed—S&P -0.29%, Nasdaq -1.05%, VIX 14.51. Weekend gap risk ahead
EverHint Signal — EMA10 × EMA30 Crossover — December 30, 2025
Fresh EMA10×EMA30 crossovers for Dec 30: 13 buy signals spanning Energy, Real Estate, and Tech, plus 21 sell signals showing momentum shifts. Markets mixed with VIX at 14.32, suggesting measured volatility heading into year-end.
EverHint Signal — EMA10 × EMA30 Crossover — December 29, 2025
44 crossover signals today: 18 buy signals led by Warner Music and Dutch Bros, 26 sell signals topped by GRAIL and Ultragenyx. Markets mixed with VIX at 14.2 as year-end trading winds down.
